Absorption |
Blood-Brain Barrier | BBB- | 0.6756 |
Human Intestinal Absorption | HIA+ | 0.9567 |
Caco-2 Permeability | Caco2- | 0.6419 |
P-glycoprotein Substrate | Substrate | 0.6619 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8943 |
Non-inhibitor | 0.8835 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9458 |
Distribution |
Subcellular localization | Mitochondria | 0.5785 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7281 |
CYP450 2D6 Substrate | Non-substrate | 0.8172 |
CYP450 3A4 Substrate | Substrate | 0.5333 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8605 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8931 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7471 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8417 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8709 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9507 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9708 |
Non-inhibitor | 0.9241 |
AMES Toxicity | Non AMES toxic | 0.7528 |
Carcinogens | Non-carcinogens | 0.6789 |
Fish Toxicity | High FHMT | 0.9555 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9868 |
Honey Bee Toxicity | Low HBT | 0.5673 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.5748 |
Carcinogenicity (Three-class) | Non-required | 0.6182 |